CLUSTER filed Jul 7, 2026 at 17:11 ET
Three Xeris Biopharma insiders (C-suite/top officers) sold a total of ~$1.0M in stock over a 7-day window ending July 6, 2026, including a $723K sale by the CEO. The selling occurred near $8.03-$8.50, just off the stock's recent highs. While the dollar amount is modest relative to the $1.4B market cap (~0.07%), the cluster includes the CEO's largest single sale in the cluster and coincides with recent positive insider selling patterns (4 sales totaling $1.2M in the prior 30 days). No 10b5-1 pattern is evident from the data provided, and the cluster lacks an offsetting buy direction.